BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2015.
World J Gastroenterol. Apr 7, 2015; 21(13): 3912-3920
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3912
Table 1 Study population characteristics n (%)
n358
Gender (M/F)281 (78.5)/77 (21.5)
Age at LT (yr, mean ± SD)52 ± 9
Donor age (yr, mean ± SD)53 ± 17
HCV Genotype
1212 (59.2)
248 (13.4)
357 (15.9)
441 (11.5)
Immunosuppression
Cyclosporine269 (75.1)
Tacrolimus83 (23.2)
Other regimens6 (1.7)
Antiviral therapy after LT
Treated150 (41.9)
Untreated208 (58.1)


Write to the Help Desk